Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Blind, Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell) Inoculated in 4-dose Program (2-1-1)

NCT05549908 is registered in ClinicalTrials.gov with Changchun Zhuoyi Biological Co., Ltd as lead sponsor.

NCT NCT05549908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05549908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Blind, Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of Freeze-dried Human Rabies Vaccine (Vero Cell) Inoculated in 4-dose Program (2-1-1)
Lead sponsor
Changchun Zhuoyi Biological Co., Ltd
Phase
Phase 3
Overall status
Completed
Start date
July 22, 2020
Completion date
April 20, 2023
Enrollment
1,800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antibody titer, rabies human